ConductScience.org, home

Paper9565366

Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.

Struyf S and 7 others. Eur J Immunol, 1998. Cited by 116 papers, by iCite.

Cite this record

ConductScience Library. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Papers, record 9565366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9565366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.
PubMed
Journal
Eur J Immunol
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
116
iCite
Relative citation ratio, by iCite
2.46
iCite
Revised in PubMed
2018-05-12
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Struyf SS
2De Meester II
3Scharpé SS
4Lenaerts JPJ P
5Menten PP
6Wang JMJ M
7Proost PP
8Van Damme JJ

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chemokine CCL5Major topic
ChemotaxisMajor topic
EosinophilsMajor topic
MonocytesMajor topic
Receptors, ChemokineMajor topic
Signal TransductionMajor topic
Cell Line
Cells, Cultured
Humans
Receptors, CCR1
Receptors, CCR3

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.

PMIDTitleJournalYearIn PapersSource
38308278Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity.Cell Commun Signal2024https://conductscience.org/library/papers/38308278PubMed
37901222A bibliometric analysis: Ca2+ fluxes and inflammatory phenotyping by flow cytometry in peripheral blood mononuclear cells.Front Immunol2023https://conductscience.org/library/papers/37901222PubMed
34503058The Role of Post-Translational Modifications of Chemokines by CD26 in Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/34503058PubMed
32259075Selective Allosteric Modulation of N-Terminally Cleaved, but Not Full Length CCL3 in CCR1.ACS Pharmacol Transl Sci2019https://conductscience.org/library/papers/32259075PubMed
27891127Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26.Front Immunol2016https://conductscience.org/library/papers/27891127PubMed
26744452CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.J Leukoc Biol2016https://conductscience.org/library/papers/26744452PubMed
25008920Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara.J Virol2014https://conductscience.org/library/papers/25008920PubMed
24912917Transplantation and inflammation: implications for the modification of chemokine function.Immunology2014https://conductscience.org/library/papers/24912917PubMed
24314089Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTES.Biophys J2013https://conductscience.org/library/papers/24314089PubMed
22708643Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.Br J Pharmacol2012https://conductscience.org/library/papers/22708643PubMed
22147696Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16.J Biol Chem2012https://conductscience.org/library/papers/22147696PubMed
19722264Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTES.Proteins2010https://conductscience.org/library/papers/19722264PubMed
17148615Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/17148615PubMed
16569870Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16569870PubMed
11287590The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.J Virol2001https://conductscience.org/library/papers/11287590PubMed
10588734Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10588734PubMed
10535605HIV infection and pathogenesis: what about chemokines?J Clin Immunol1999https://conductscience.org/library/papers/10535605PubMed
10430618CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation.J Exp Med1999https://conductscience.org/library/papers/10430618PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9565366

GET https://conductscience.org/api/papers/v1/9565366/authors